Inovio Pharmaceuticals

Inovio Pharmaceuticals

Yahoo Finance • 2 months ago

Inovio gains on late-stage trial win for DNA shot

Shares of Inovio Pharmaceuticals (INO [https://seekingalpha.com/symbol/INO]) traded higher on Friday after its partner in China, ApolloBio, succeeded in a Phase 3 pivotal trial for its therapeutic DNA vaccine, VGX-3100, against cervical dy... Full story

Yahoo Finance • 2 months ago

Earnings Snapshot: Inovio Pharmaceuticals' Q1 shows EPS beat; net loss $19.7M improves as R&D costs fall

[Inovio Pharmaceuticals Q1 report: EPS beats expectations, net loss narrows] Earnings Snapshot (Seeking Alpha) MORE ON INOVIO PHARMACEUTICALS * Inovio Pharmaceuticals, Inc. (INO) Presents at World Federation of Hemophilia World Cong... Full story

Yahoo Finance • 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors

LOS ANGELES, April 06, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Inovio Pharmaceuticals, Inc., (“Inovio” or the "Company") (NASDAQ: INO) investors of a class action on behalf of investors that bought securities between Octobe... Full story

Yahoo Finance • 3 months ago

DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, April 06, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story

Yahoo Finance • 3 months ago

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, April 06, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. (“Inovio” or “the Company”) (NASDAQ: INO... Full story

Yahoo Finance • 3 months ago

Inovio prices $17.5 million public offering of shares and warrants

* INOVIO Pharmaceuticals (Nasdaq: INO [https://seekingalpha.com/symbol/INO]) on Thursday said it has priced an underwritten public offering expected to raise about $17.5 million in gross proceeds. * The offering consists of 12.5 millio... Full story

Yahoo Finance • 3 months ago

INOVIO Pharmaceuticals proposes securities offering

* INOVIO Pharmaceuticals (INO [https://seekingalpha.com/symbol/INO]) plans to sell common shares and accompanying Series A warrants and Series B warrants (or pre-funded warrants to purchase its common stock in lieu thereof), in an underw... Full story

Yahoo Finance • 4 months ago

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) and certain officers.   The class action, file... Full story

Yahoo Finance • 4 months ago

INO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusiv... Full story

Yahoo Finance • 4 months ago

INO Shareholder Alert: Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Inovio Pharmaceuticals, Inc. (NASDAQ: INO). Shareholders who purchased shares of INO during the class period listed are encou... Full story

Yahoo Finance • 4 months ago

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inovio (INO) To Contact Him Directly To Discuss Their Options If you purchased or acquired Inovio securities between October 10, 202... Full story

Yahoo Finance • 4 months ago

INO DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusiv... Full story

Yahoo Finance • 4 months ago

DEADLINE ALERT for ORCL, PSFE, INO, KD: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story

Yahoo Finance • 4 months ago

Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, March 19, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 7, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or... Full story

Yahoo Finance • 4 months ago

INO DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INO

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusiv... Full story

Yahoo Finance • 4 months ago

INO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inovio To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inovio between October 1... Full story

Yahoo Finance • 4 months ago

Holzer & Holzer, LLC Reminds Investors of April 7, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Inovio Pharmaceuticals, Inc. (INO) and Paysafe Limited (PSFE)

ATLANTA, March 17, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Inovio Pharmaceuticals, Inc. (INO) The shareholder class... Full story

Yahoo Finance • 4 months ago

Inovio targets October 30 PDUFA date for INO-3107 approval while extending cash runway into Q4 2026

Earnings Call Insights: Inovio Pharmaceuticals (INO) Q4 2025 MANAGEMENT VIEW * CEO Jacqueline Shea highlighted that "these are very exciting times for Inovio with our first BLA for INO-3107 as a potential treatment for adults with recu... Full story

Yahoo Finance • 4 months ago

Inovio Pharmaceuticals GAAP EPS of -$1.81 beats by $0.42

* Inovio Pharmaceuticals press release [https://seekingalpha.com/pr/20435970-inovio-reports-fourth-quarter-and-full-year-2025-financial-results-and-recent-business] (INO [https://seekingalpha.com/symbol/INO]): FY GAAP EPS of -$1.81 beats... Full story

Yahoo Finance • 4 months ago

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO

NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusiv... Full story